 |
The Journal of Neuroscience, December 15, 2004, 24(50):11421-11428; doi:10.1523/JNEUROSCI.2251-04.2004
Previous Article | Next Article 
Development/Plasticity/Repair
Impaired Synaptic Function in the Microglial KARAP/DAP12-Deficient Mouse
Anne Roumier,1 *
Catherine Béchade,1 *
Jean-Christophe Poncer,2 *
Karl-Heinz Smalla,3
Elena Tomasello,4
Eric Vivier,4
Eckart D. Gundelfinger,3
Antoine Triller,1 and
Alain Bessis1
1Laboratoire de Biologie Cellulaire de la Synapse Normale et Pathologique, Institut National de la Santé et de la Recherche Médicale (INSERM) U497, Ecole Normale Supérieure, 75230 Paris Cedex 05, France, 2 INSERM EMI0224, Cortex and Epilepsie, 75013 Paris, France, 3Department of Neurochemistry and Molecular Biology, Leibniz Institute for Neurobiology, 39118 Magdeburg, Germany, and 4Centre d'Immunologie INSERM-Centre National de la Recherche Scientifique de Marseille-Luminy, 13288 Marseille Cedex 09, France
Several proteins are expressed in both immune and nervous systems. However, their putative nonimmune functions in the brain remain poorly understood. KARAP/DAP12 is a transmembrane polypeptide associated with cell-surface receptors in hematopoeitic cells. Its mutation in humans induces Nasu-Hakola disease, characterized by presenile dementia and demyelinization. However, alteration of white matter occurs months after the onset of neuropsychiatric symptoms, suggesting that other neuronal alterations occur in the early phases of the disease. We hypothesized that KARAP/DAP12 may impact synaptic function. In mice deficient for KARAP/DAP12 function, long-term potentiation was enhanced and was partly NMDA receptor (NMDAR) independent. This effect was accompanied by changes in synaptic glutamate receptor content, as detected by the increased rectification of AMPA receptor EPSCs and increased sensitivity of NMDAR EPSCs to ifenprodil. Biochemical analysis of synaptic proteins confirmed these electrophysiological data. In mutants, the AMPA receptor GluR2 subunit expression was decreased only in the postsynaptic densities but not in the whole membrane fraction, demonstrating specific impairment of synaptic receptor accumulation. Alteration of the BNDF-tyrosine kinase receptor B (TrkB) signaling in the mutant was demonstrated by the dramatic decrease of synaptic TrkB with no change in other regulatory or scaffolding proteins. Finally, KARAP/DAP12 was detected only in microglia but not in neurons, astrocytes, or oligodendrocytes. KARAP/DAP12 may thus alter microglial physiology and subsequently synaptic function and plasticity through a novel microglia-neuron interaction.
Key words: synapse; microglia; LTP; glutamate receptor; BDNF; hippocampus; postsynaptic density
Received June 9, 2004;
revised November 5, 2004;
accepted November 7, 2004.
This article has been cited by other articles:

|
 |

|
 |
 
S. Thams, P. Brodin, S. Plantman, R. Saxelin, K. Karre, and S. Cullheim
Classical Major Histocompatibility Complex Class I Molecules in Motoneurons: New Actors at the Neuromuscular Junction
J. Neurosci.,
October 28, 2009;
29(43):
13503 - 13515.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Wakselman, C. Bechade, A. Roumier, D. Bernard, A. Triller, and A. Bessis
Developmental Neuronal Death in Hippocampus Requires the Microglial CD11b Integrin and DAP12 Immunoreceptor
J. Neurosci.,
August 6, 2008;
28(32):
8138 - 8143.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Weigelt, W. Ernst, Y. Walczak, S. Ebert, T. Loenhardt, M. Klug, M. Rehli, B. H. F. Weber, and T. Langmann
Dap12 expression in activated microglia from retinoschisin-deficient retina and its PU.1-dependent promoter regulation
J. Leukoc. Biol.,
December 1, 2007;
82(6):
1564 - 1574.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Langmann
Microglia activation in retinal degeneration
J. Leukoc. Biol.,
June 1, 2007;
81(6):
1345 - 1351.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|

|